Association Between Omega‐3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA

BACKGROUND: Randomized trials of pharmacologic strength omega‐3 fatty acid (n3‐FA)–based therapies suggest a dose‐dependent cardiovascular benefit. Whether blood n3‐FA levels also mediate safety signals observed in these trials, such as increased bleeding and atrial fibrillation (AF), remains uncert...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Karan, Alfaddagh, Abdulhamied, Al Rifai, Mahmoud, Bhatt, Deepak L., Budoff, Matthew J., Nasir, Khurram, Miller, Michael, Welty, Francine K., McEvoy, J. William, Dardari, Zeina, Shapiro, Michael D., Blumenthal, Roger S., Tsai, Michael Y., Blaha, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483537/
https://www.ncbi.nlm.nih.gov/pubmed/34041918
http://dx.doi.org/10.1161/JAHA.121.021431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483537/
https://www.ncbi.nlm.nih.gov/pubmed/34041918
http://dx.doi.org/10.1161/JAHA.121.021431

Ejemplares similares